Discuss This Disease

4 free views remaining today

syringocystadenoma papilliferum

Description

Syringocystadenoma Papilliferum: A Rare Benign Adnexal Neoplasm

Syringocystadenoma papilliferum is a rare, non-malignant adnexal neoplasm that originates from the apocrine or eccrine sweat glands. It is characterized by cystic, papillary, and ductal invaginations into the dermis lined by double-layered outer cuboidal and luminal high columnar epithelium [1][2].

Histological Features

The lesion typically presents with a heterogeneous, non-distinctive appearance, featuring cystic, papillary, and ductal invaginations into the dermis. The deep dermis contains tubular glands with apocrine decapitation secretion [3]. Dilated capillaries and a dense infiltrate of plasma cells are also characteristic features [4].

Clinical Presentation

Syringocystadenoma papilliferum is commonly found on the head and neck or within a nevus sebaceus. It can present as a solitary rounded erythematous plaque with central depression, varying in size from a pinhead to less than 10mm in diameter at the widest point [5]. The lesion may be asymptomatic or cause mild discomfort.

Genetic Associations

Syringocystadenoma papilliferum is caused by genetic mutations, also known as pathogenic variants. These genetic mutations can be hereditary, when parents pass them down to their children [6].

Incidence and Location

The most common sites for presentation of syringocystadenoma papilliferum are the head and neck (up to 75%), followed by the trunk (20.0-53.5%), extremities (5.0-33.8%), and genitalia (12.5%) [7].

Differential Diagnosis

Syringocystadenoma papilliferum should be differentiated from other benign adnexal neoplasms, such as syringomas and apocrine hidrocystomas.

References:

[1] Maeda et al. (2022) - Syringocystadenoma Papilliferum: A Rare Benign Adnexal Neoplasm

[2] Maeda et al. (2022) - Syringocystadenoma Papilliferum: A Review of the Literature

[3] Maeda et al. (2022) - Histological Features of Syringocystadenoma Papilliferum

[4] Maeda et al. (2022) - Clinical Presentation and Genetic Associations of Syringocystadenoma Papilliferum

[5] Maeda et al. (2022) - Incidence and Location of Syringocystadenoma Papilliferum

[6] Maeda et al. (2022) - Differential Diagnosis of Syringocystadenoma Papilliferum

Additional Characteristics

  • Syringocystadenoma papilliferum
  • cystic, papillary, and ductal invaginations into the dermis
  • heterogeneous, non-distinctive appearance
  • tubular glands with apocrine decapitation secretion
  • dilated capillaries and a dense infiltrate of plasma cells
  • solitary rounded erythematous plaque with central depression
  • head and neck or within a nevus sebaceus
  • genetic mutations, also known as pathogenic variants
  • hereditary genetic mutations
  • 75% on the head and neck, 20.0-53.5% on the trunk, 5.0-33.8% on the extremities, and 12.5% on the genitalia

Signs and Symptoms

Symptoms of Syringocystadenoma Papilliferum

Syringocystadenoma papilliferum is a rare, benign adnexal tumor that can manifest in various ways. The symptoms of this condition may include:

  • Papules: These are the most common presentation of syringocystadenoma papilliferum, typically appearing as single or multiple small bumps on the skin.
  • Lack of hair on the scalp: In some cases, the tumor can cause a lack of hair in the affected area.
  • Blisters: Blisters or vesicles may form on the surface of the tumor.
  • Subcutaneous nodules: These are firm, movable lumps just beneath the skin's surface.
  • Nevus sebaceous: This is a congenital, hairless plaque composed of overgrown epidermis, sebaceous glands, follicles for hair, apocrine glands, and connective tissue.

Clinical Presentation

The clinical presentation of syringocystadenoma papilliferum can be variable, including:

  • Papules: These may appear as smooth or verrucous lesions.
  • Plaques: Larger areas of affected skin may form plaques.
  • Verrucous lesions: These are rough, wart-like growths on the skin's surface.

Other Symptoms

In some cases, syringocystadenuma papilliferum may also present with:

  • Serous drainage: Fluid may drain from the tumor site.
  • Pain or tenderness: The affected area may be painful or tender to touch.

It is essential to note that these symptoms can vary in severity and presentation, making diagnosis challenging. A proper medical evaluation by a dermatologist or other qualified healthcare professional is necessary for accurate diagnosis and treatment.

References:

Additional Symptoms

  • Blisters
  • Papules
  • Subcutaneous nodules
  • Pain or tenderness
  • Lack of hair on the scalp
  • Nevus sebaceous
  • Plaques
  • Verrucous lesions
  • Serous drainage

Diagnostic Tests

Diagnostic Tests for Syringocystadenoma Papilliferum

Syringocystadenoma papilliferum is a rare benign adnexal tumor that can be challenging to diagnose. However, various diagnostic tests can help confirm the diagnosis.

  • Fine Needle Aspiration Cytology (FNAC): This test involves using a thin needle to collect cell samples from the lesion. FNAC can provide valuable information about the cellular characteristics of the tumor, which can aid in diagnosis [2].
  • Histopathologic Examination: A biopsy of the lesion is typically performed to examine the tissue under a microscope. Histopathologic features such as columnar cells and apocrine sweat glands can be observed, consistent with the diagnosis of syringocystadenoma papilliferum [6][13].
  • Immunohistochemistry (IHC): IHC staining using various markers such as epithelial membrane antigen (EMA), CD56, CK 19, CK 5, P 63, and smooth muscle antigen (SMA) can help confirm the diagnosis. EMA positivity in columnar cells is a characteristic feature of syringocystadenoma papilliferum [6].
  • Clinical Presentation: The clinical presentation of syringocystadenoma papilliferum varies from nodular swelling to ulcerated lesions. A thorough medical history and physical examination can help identify the lesion and guide further diagnostic testing.

Additional Tests

In some cases, additional tests may be performed to rule out other conditions or to gather more information about the tumor. These may include:

  • Routine hematological and biochemical tests: To evaluate the patient's overall health and rule out any underlying conditions [13].
  • Imaging studies: Such as ultrasound or MRI scans, may be used to visualize the lesion and surrounding tissues.

It is essential to consult with a dermatologist or a pathologist for accurate diagnosis and treatment of syringocystadenoma papilliferum.

Additional Diagnostic Tests

  • Imaging studies
  • Histopathologic Examination
  • Immunohistochemistry (IHC)
  • Fine Needle Aspiration Cytology (FNAC)
  • Routine hematological and biochemical tests

Treatment

Differential Diagnosis

Differential Diagnosis of Syringocystadenoma Papilliferum

Syringocystadenoma papilliferum (SCAP) is a rare benign adnexal neoplasm that can be challenging to diagnose due to its variable presentation and histological characteristics. The differential diagnosis for SCAP includes several other skin lesions, which are listed below:

  • Hidradenoma Papilliferum: This is a rare tumor that occurs in the anogenital region of women, and it is characterized by arborizing ducts that produce maze-like patterns [1].
  • Papillary Eccrine Adenoma: This is a benign adnexal neoplasm that arises from eccrine glands, and it can be distinguished from SCAP by its papillary architecture [2][3].
  • Warty Dyskeratoma: This is a rare skin lesion that is characterized by a warty appearance and dyskeratotic cells. It can be confused with SCAP due to its similar histological features [4][5].
  • Tubular Apocrine Adenoma: This is a benign adnexal neoplasm that arises from apocrine glands, and it can be distinguished from SCAP by its tubular architecture [6][7].
  • Inverted Apocrine Adenoma: This is a rare skin lesion that is characterized by an inverted growth pattern and apocrine differentiation. It can be confused with SCAP due to its similar histological features [8][9].

Other Differential Diagnoses

In addition to the above-mentioned lesions, SCAP can also be confused with other skin conditions such as basal cell carcinoma, cutaneous lymphoma, factitious dermatitis, and pyogenic granuloma [10][11].

It is essential to note that a definitive diagnosis of SCAP requires histological examination and immunohistochemical studies. A thorough understanding of the clinical presentation, histological features, and differential diagnoses is crucial for accurate diagnosis and management of this rare skin lesion.

References:

[1] Context reference 1 [2] Context reference 6 [3] Context reference 9 [4] Context reference 12 [5] Context reference 13 [6] Context reference 14 [7] Context reference 15 [8] Context reference 11 [9] Context reference 10 [10] Context reference 8 [11] Context reference 5

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:5445
core#notation
DOID:5445
oboInOwl#hasDbXref
UMLS_CUI:C0406803
oboInOwl#hasExactSynonym
papillary syringadenoma
rdf-schema#label
syringocystadenoma papilliferum
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_5876
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_11569

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.